Lucid Diagnostics Inc. financial data

Symbol
LUCD on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118% % -0.68%
Quick Ratio 2% % -38%
Debt-to-equity 361% % 37%
Return On Equity -632% % -13%
Return On Assets -137% % 11%
Operating Margin -1091% % -1.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137,508,926 shares 148%
Common Stock, Shares, Outstanding 130,924,686 shares 154%
Entity Public Float $14,600,000 USD 1.4%
Common Stock, Value, Issued $131,000 USD 152%
Weighted Average Number of Shares Outstanding, Basic 108,176,088 shares 115%
Weighted Average Number of Shares Outstanding, Diluted 108,176,088 shares 115%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $4,399,000 USD 5%
Revenue from Contract with Customer, Excluding Assessed Tax $4,399,000 USD 5%
Research and Development Expense $5,408,000 USD -16%
Selling and Marketing Expense $16,370,000 USD -3%
General and Administrative Expense $23,248,000 USD 26%
Operating Income (Loss) $48,004,000 USD -6.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $53,285,000 USD -19%
Net Income (Loss) Attributable to Parent $53,285,000 USD -19%
Earnings Per Share, Basic 0 USD/shares 23%
Earnings Per Share, Diluted 0 USD/shares 23%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $47,332,000 USD 227%
Accounts Receivable, after Allowance for Credit Loss, Current $550,000 USD 1310%
Inventory, Net $486,000 USD -25%
Assets, Current $49,842,000 USD 196%
Property, Plant and Equipment, Net $862,000 USD -8.3%
Operating Lease, Right-of-Use Asset $2,021,000 USD -29%
Intangible Assets, Net (Excluding Goodwill) $421,000 USD -50%
Other Assets, Noncurrent $52,000 USD -95%
Assets $53,198,000 USD 135%
Accounts Payable, Current $751,000 USD -34%
Employee-related Liabilities, Current $1,479,000 USD 26%
Liabilities, Current $26,206,000 USD 84%
Operating Lease, Liability, Noncurrent $1,157,000 USD -42%
Liabilities $27,363,000 USD 68%
Retained Earnings (Accumulated Deficit) $258,069,000 USD -34%
Stockholders' Equity Attributable to Parent $25,835,000 USD 308%
Liabilities and Equity $53,198,000 USD 135%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,465,000 USD 1.2%
Net Cash Provided by (Used in) Financing Activities $15,438,000 USD -17%
Net Cash Provided by (Used in) Investing Activities $93,000 USD -151%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 130,924,686 shares 154%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,880,000 USD -51%
Deferred Tax Assets, Valuation Allowance $52,376,000 USD 24%
Deferred Tax Assets, Gross $53,108,000 USD 26%
Operating Lease, Liability $2,035,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid $2,212,000 USD -31%
Property, Plant and Equipment, Gross $2,209,000 USD 5.1%
Operating Lease, Liability, Current $878,000 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $942,000 USD -3.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $998,000 USD -2.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $177,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid, Year Three $19,000 USD -98%
Deferred Tax Assets, Operating Loss Carryforwards $39,472,000 USD 36%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $19,000 USD -21%
Operating Lease, Payments $267,000 USD -12%
Additional Paid in Capital $229,499,000 USD 61%
Amortization of Intangible Assets $421,000 USD -61%
Depreciation, Depletion and Amortization $221,000 USD -56%
Deferred Tax Assets, Net of Valuation Allowance $52,376,000 USD 24%
Share-based Payment Arrangement, Expense $4,497,000 USD 4%
Interest Expense $24,000 USD -20%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%